Intermediate AMD Market Size

Market Size in USD Bn

CAGR5.7%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	5.7%
Market Concentration	Medium
Major Players	Alkeus Pharmaceuticals, Apellis Pharmaceuticals, Iveric Bio, Roche, Regeneron Pharmaceuticals and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Intermediate AMD Market Analysis

The intermediate AMD market is estimated to be valued at USD 1.10 Bn in 2025 and is expected to reach USD 1.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. Rising prevalence of AMD in geriatric population and growing need for effective treatment are expected to remain the top drivers of the intermediate AMD market in the coming years.